Note: Information in older articles may not be the latest.
Recent changes to the processing of pathology reports for My Health Record has elevated the importance of pre-test counselling around implications of test results, where to go for further information, and confidentiality.
In this issue: Testing Saves Lives |Malhotra Syndrome - what is it? | What SA did during World Hep Day | DAA Hep C cure rates | Hep B treatment: good & bad news | Supporting families who support users | In Our Library
Findings from the Australian Needle and Syringe Program (NSP) Survey 30-year National Data Report shows highly significant reductions in hepatitis C infections and high levels of treatment and cure among NSP clients. Nationally the proportion of respondents with active hepatitis C infection (HCV RNA positive) declined substantially, from 51% in 2015 to 8% in 2024.
South Australian pharmacists can now administer long-acting injectable buprenorphine bringing SA in line with other Australian jurisdictions.
Hepatitis Australia is calling for national roll out universal hepatitis B testing for people over the age of 25.In a statement issued 8 April, Hepatitis Australia CEO, Lucy Clynes, said universal testing for hepatitis B is the next crucial step in eliminating hepatitis B and reducing liver cancer.
Every year, nearly 1000 people in Australia die from hepatitis B and C. Close to 300,000 are living with viral hepatitis. We have the tools to stop this - it's time for action.
27 May is the anniversary of the 1967 referendum where Australians voted to remove clauses from the Australian Constitution that discriminated against Aboriginal and Torres Strait Islander people; and 3 June is the anniversary of the 1992 High Court Mabo decision – the recognition that Aboriginal and Torres Strait Islander peoples’ rights over their lands did survive British colonisation.
In this issue: Mouse Model for HCV Vaccine | Pathogens Don't Care About Your Politics | Measles & Liver Health | Hep D Action Needed | Community Testing | Hep B & Liver Cancer | Closing the Ever-Widening Gap
The sudden freezing of USAID is jeopardising the elimination of viral hepatitis by 2030, the Lancet Gastroenterology & Hepatology said, asking: “What are their implications for viral hepatitis elimination, for which progress has already stalled?
The Take Home Naloxone (THN) program funds pharmacies to provide Naloxone free to people who use opioids or who know someone who does. Use these maps to find your nearest naloxone pharmacy.
According to the World Health Organization (WHO) 2024 Global Hepatitis Report, the number of lives lost due to viral hepatitis is increasing. The disease is the second leading infectious cause of death globally -- with 1.3 million deaths per year, the same as tuberculosis, a top infectious killer, second only to COVID-19.
In this issue:
Celebrating 100 issues | In Memory of Mark Tiller | Hep C Drug Resistance | In Our Library: Living Well with Hepatitis | Community News - a Look Back | Waking to a New Life...
